An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma.

Saved in:
Bibliographic Details
Title: An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma.
Authors: Belogurova, Margarita B.1 (AUTHOR) deton.hospital31@inbox.ru, Lammerich, Andreas2 (AUTHOR), Barkay, Hadas3 (AUTHOR), Seo, Dayoung4 (AUTHOR), Buchner, Anton2 (AUTHOR)
Source: Scientific Reports. 11/12/2025, Vol. 15 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-23258-7